Why ME?
Harry Sparks went for a second opinion after he was diagnosed with pancreatic cancer, and was able to have Whipple surgery.
NALIRIFOX Shows Promise in Early Studies
Dr. Zev Wainberg describes the new combination NALIRIFOX, being tested in the NAPOLI-3 clinical trial for advanced pancreatic cancer patients.
Planning Every Day to Live
Tammy Richardson has focused her pancreatic cancer treatment choices on maintaining her quality of life, so she can travel and see family as much as possible.
Working Hard to Beat Pancreatic Cancer
Sandy Robis underwent a full pancreatectomy and chemotherapy to help her beat pancreatic cancer. Now she helps support other patients.
DIRECT Study Focuses on NanoKnife Technology
Dr. Daniel Holzwanger is part of the NanoKnife irreversible electroporation (IRE) study for stage III pancreatic cancer patients.
Pancreatic Cancer Caught Early Because of My Vigilance
Beverly Leighton joined a screening study and underwent genetic testing because of her family history of pancreatic cancer.
Genetic Testing Leads Me to a PARP Inhibitor Trial
Harvey Parker had genetic testing as part of his initial pancreatic cancer treatment. The BRCA2 mutation led him to a PARP inhibitor clinical trial when the cancer returned.
A Genetic Mutation Aids My Treatment
Malcolm Robertson carries the BRCA2 mutation, so when he was diagnosed with pancreatic cancer, platinum-based chemo was part of his treatment.
Strong Like a Dinosaur
Diagnosed with pancreatic cancer on her 40th birthday, Andrea Barkstrom receives chemotherapy and is living up to her motto: Strong Like a Dinosaur.
My Pancreatic Cancer Clinical Trial Journey
After starting pancreatic cancer treatment, Davi D'Agostino discovered she has the BRCA2 mutation, which made her eligible for a clinical trial.
